SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-036503
Filing Date
2023-02-14
Accepted
2023-02-13 21:09:59
Documents
17
Period of Report
2023-02-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d452795d8k.htm   iXBRL 8-K 47026
2 EX-10.1 d452795dex101.htm EX-10.1 78088
3 EX-10.2 d452795dex102.htm EX-10.2 94594
4 EX-99.1 d452795dex991.htm EX-99.1 17575
8 GRAPHIC g452795g0214023600085.jpg GRAPHIC 4866
9 GRAPHIC g452795g0214024656872.jpg GRAPHIC 659
  Complete submission text file 0001193125-23-036503.txt   431970

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA elym-20230207.xsd EX-101.SCH 2838
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE elym-20230207_lab.xml EX-101.LAB 18737
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elym-20230207_pre.xml EX-101.PRE 11699
11 EXTRACTED XBRL INSTANCE DOCUMENT d452795d8k_htm.xml XML 3480
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 23621505
SIC: 2834 Pharmaceutical Preparations